4//SEC Filing
Suri Anish 4
Accession 0001209191-22-021458
CIK 0001645460other
Filed
Mar 28, 8:00 PM ET
Accepted
Mar 29, 4:15 PM ET
Size
7.7 KB
Accession
0001209191-22-021458
Insider Transaction Report
Form 4
Suri Anish
Chief Scientific Officer
Transactions
- Award
Stock Option (right to buy)
2022-03-25+21,333→ 21,333 totalExercise: $5.01Exp: 2032-03-24→ Common Stock (21,333 underlying) - Award
Stock Option (right to buy)
2022-02-09+82,000→ 82,000 totalExercise: $6.91Exp: 2032-02-08→ Common Stock (82,000 underlying)
Footnotes (2)
- [F1]1. This stock option grant becomes exercisable in eight equal semi-annual installments beginning August 9, 2022.
- [F2]2. This stock option grant becomes exercisable in eight equal semi-annual installments beginning September 25, 2022.
Documents
Issuer
Cue Biopharma, Inc.
CIK 0001645460
Entity typeother
Related Parties
1- filerCIK 0001739130
Filing Metadata
- Form type
- 4
- Filed
- Mar 28, 8:00 PM ET
- Accepted
- Mar 29, 4:15 PM ET
- Size
- 7.7 KB